Louise Prescott Chapman, MA, NCC, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 4216 Mosby Street, The Plains, VA 20198 Phone: 540-687-1020 |
News Archive
A substantial proportion of NK/T-cell lymphomas harbor Janus Kinase 3 gene mutations. Patients with these lymphomas might benefit from treatment with a Janus Kinase inhibitor according to a study published in Cancer Discovery, a journal of the American Association for Cancer Research.
A new mechanism for guiding the growth of nerves that involves cell-death machinery has been found by scientists at the University of Nevada, Reno that may bring advances in neurological medicine and research.
Roll Call published a special section today that pulls together opinion pieces from 20 major players from all corners of the health care debate, including Tom Daschle, Michael Tanner, Dick Gephardt and Tommy Thompson and Newt Gingrich and Jim Frogue.
Ablation procedures restore a regular heartbeat in patients who have a dangerous, abnormal heart rhythm called atrial fibrillation. But it doesn't always work. Now, a new study suggests that certain molecules are associated with the recurrence of erratic heartbeats in some patients after ablation therapy.
The US Food and Drug Administration (FDA) has approved Extavia(R) (interferon beta-1b), the first in a new planned portfolio of multiple sclerosis (MS) medicines from Novartis to help patients manage this devastating disease.
› Verified 5 days ago